(Q28377689)

1

0 references

D E Michele

2

0 references

J Park

3

0 references

A M Smart

4

0 references

Z Lin

5

0 references

F C Brosius

6

0 references

J B Schnermann

7

0 references

J P Briggs

American Journal of Physiology

8

0 references

language of work or name

English

0 references

publication date

December 1999

0 references

published in

0 references

volume

277

0 references

issue

6 Pt 2

0 references

page(s)

F966-73

0 references

cites work

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Biological activities and mechanisms of action of PGJ2 and related compounds: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

21 January 2018

Regulating adipogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Cyclic nucleotide-gated cation channels mediate sodium absorption by IMCD (mIMCD-K2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

Differential expression of PPAR gamma1 and gamma2 isoforms in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966

RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.1999.277.6.F966